Skip to main content

Table 1 Demographics at the time of their first cardiovascular magnetic resonance scan

From: Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy

 

Mean ± SD or N (%)

Age (years)

14 ± 5

Height (m)

1.46 ± 0.18 (n = 65)

Weight (kg)

50.1 ± 17.8

BSA (m2)

1.41 ± 0.32

Ambulatory

17(26%)

Medications at baseline CMR

 

 Corticosteroid

33 (50%)

 Angiotensin converting enzyme inhibitor

33 (50%)

 Beta blocker

24 (36%)

 Aldosterone inhibitor

4 (6%)

 Angiotensin receptor blocker

6(9%)

LVEF (%)

54.3 ± 9.7

LVEDV (mL)

LVEDVI (mL/m2)

93 ± 42

67 ± 20 (n = 65)

LVESV (mL)

LVESVI (mL/m2)

45 ± 33

32 ± 17 (n = 65)

LV mass (g)

Indexed LV mass (g/m2)

71 ± 27

49 ± 13 (n = 65)

Global native T1 (ms)

1048 ± 44 (n = 54)

Global εcc (%)

− 14.1 ± 3.5 (n = 64)

Presence of late gadolinium enhancement (LGE)

44 (70%)

Full width half maximum quantification of LGE (%)

21.3 ± 18.4 (n = 60)

GSS = 0

19 (30%)

GSS = 1

12 (19%)

GSS = 2

12 (19%)

GSS = 3

13 (21%)

GSS = 4

7 (11%)

  1. N = 66 unless otherwise indicated
  2. BSA body surface area, GSS global severity score, LGE late gadolinium enhancement, LV left ventricular, LVEDV left ventricular end-diastolic volume, LVEDVI left ventricular end-diastolic volume index, LVEF left ventricular ejection fraction, LVESV left ventricular end-systolic volume, LVESVI left ventricular end-systolic volume index